Long-term Safety of Rivastigmine Capsule and Patch in Patients With Mild to Moderately-severe Dementia Associated With Parkinson's Disease (PDD)

Parkinson's Disease Dementia Clinical Trial

Official title:
A 76-week Prospective, Open-label, Multicenter Study to Evaluate the Long-term Effect of Rivastigmine Capsule and Transdermal Patch on Worsening of the Underlying Motor Symptoms of PD in Patients With Mild to Moderately Severe Dementia Associated With Parkinson's Disease (PDD)

Status Completed

Clinical Trial Summary

The purpose of this study is to provide long-term safety data for rivastigmine capsule and transdermal patch treatments, in particular the effect of rivastigmine on worsening of the underlying motor symptoms of Parkinson's Disease (PD), in patients with mild to moderately severe dementia associated with PD.

Clinical Trial Description

n/a

Study Design

Allocation: Randomized, Endpoint Classification: Safety/Efficacy Study, Intervention Model: Parallel Assignment, Masking: Open Label, Primary Purpose: Treatment

Related Conditions & MeSH terms

Clinical Trial Details

NCT number	NCT00623103
Study type	Interventional
Source	Novartis
Contact
Status	Completed
Phase	Phase 3
Start date	January 2008

View Details

See also
Status	Clinical Trial	Phase
Completed	`NCT02910102` - Study Evaluating Intepirdine (RVT-101) on Gait and Balance in Subjects With Dementia	Phase 2
Terminated	`NCT02871427` - Open-label Study of Nelotanserin in Lewy Body Dementia With Visual Hallucinations or REM Sleep Behavior Disorder	Phase 2
Active, not recruiting	`NCT02914366` - Ambroxol as a Treatment for Parkinson's Disease Dementia	Phase 2
Completed	`NCT02281474` - Nilotinib in Cognitively Impaired Parkinson Disease Patients 001	Phase 1
Completed	`NCT02708186` - Study Evaluating Nelotanserin for Treatment of REM Sleep Behavior Disorder in Subjects With Dementia (DLB or PDD)	Phase 2
Completed	`NCT00855686` - Memantine Versus Placebo in Parkinson's Disease Dementia or Dementia With Lewy Bodies	Phase 4
Recruiting	`NCT04844060` - Cerebro Spinal Fluid Collection (CSF)
Recruiting	`NCT03413384` - To Assess the Efficacy and Safety of Ceftriaxone in Patients With Mild to Moderate Parkinson's Disease Dementia	Phase 2
Completed	`NCT02702102` - Imaging Inflammation in Patients With Parkinson's Disease Dementia or Dementia With Lewy Bodies	Phase 2
Completed	`NCT01102582` - An Observational Study for the Prevalence of Neuropsychiatric Symptom in Parkinson's Disease Dementia	N/A